Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Positron-Emission Tomography | 27 | 2023 | 6259 | 2.150 |
Why?
|
| Potassium Channels | 2 | 2021 | 562 | 1.230 |
Why?
|
| Radiopharmaceuticals | 10 | 2022 | 2658 | 1.200 |
Why?
|
| tau Proteins | 7 | 2023 | 1860 | 1.030 |
Why?
|
| Myocardial Perfusion Imaging | 3 | 2020 | 555 | 0.980 |
Why?
|
| Radioactive Tracers | 2 | 2022 | 73 | 0.960 |
Why?
|
| Isoquinolines | 2 | 2019 | 368 | 0.760 |
Why?
|
| Fluorine Radioisotopes | 2 | 2020 | 448 | 0.730 |
Why?
|
| Receptors, Metabotropic Glutamate | 4 | 2022 | 212 | 0.730 |
Why?
|
| Coronary Circulation | 3 | 2020 | 1572 | 0.610 |
Why?
|
| Coronary Vessels | 2 | 2020 | 3099 | 0.590 |
Why?
|
| Aminopyridines | 1 | 2020 | 541 | 0.580 |
Why?
|
| Pyridazines | 1 | 2017 | 201 | 0.520 |
Why?
|
| Rest | 2 | 2017 | 900 | 0.520 |
Why?
|
| Alzheimer Disease | 5 | 2023 | 7988 | 0.510 |
Why?
|
| 4-Aminopyridine | 2 | 2022 | 81 | 0.410 |
Why?
|
| Demyelinating Diseases | 2 | 2022 | 363 | 0.360 |
Why?
|
| Stress, Physiological | 1 | 2017 | 1402 | 0.340 |
Why?
|
| Brain Injuries | 1 | 2020 | 2024 | 0.320 |
Why?
|
| Swine | 7 | 2023 | 5934 | 0.310 |
Why?
|
| Brain | 13 | 2023 | 26343 | 0.250 |
Why?
|
| Kv1.2 Potassium Channel | 1 | 2022 | 15 | 0.220 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2022 | 29 | 0.220 |
Why?
|
| Molecular Imaging | 2 | 2022 | 831 | 0.220 |
Why?
|
| Ice | 1 | 2023 | 104 | 0.210 |
Why?
|
| Pyrans | 1 | 2022 | 53 | 0.200 |
Why?
|
| Picolinic Acids | 1 | 2022 | 53 | 0.200 |
Why?
|
| Radiochemistry | 1 | 2021 | 56 | 0.190 |
Why?
|
| Cromolyn Sodium | 1 | 2021 | 87 | 0.190 |
Why?
|
| Macaca mulatta | 3 | 2023 | 2378 | 0.190 |
Why?
|
| Haplorhini | 1 | 2021 | 551 | 0.180 |
Why?
|
| Nitrogen Isotopes | 1 | 2020 | 84 | 0.180 |
Why?
|
| Animals | 21 | 2023 | 168561 | 0.170 |
Why?
|
| Ammonia | 1 | 2020 | 239 | 0.170 |
Why?
|
| Aniline Compounds | 1 | 2023 | 983 | 0.160 |
Why?
|
| Autoradiography | 1 | 2019 | 749 | 0.160 |
Why?
|
| Football | 1 | 2023 | 460 | 0.150 |
Why?
|
| Radiometry | 1 | 2022 | 800 | 0.150 |
Why?
|
| Neuralgia | 1 | 2023 | 568 | 0.150 |
Why?
|
| Microspheres | 1 | 2020 | 777 | 0.150 |
Why?
|
| Phosphatidylcholines | 1 | 2018 | 411 | 0.140 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2018 | 297 | 0.140 |
Why?
|
| Regional Blood Flow | 1 | 2020 | 1525 | 0.140 |
Why?
|
| Lymphangioleiomyomatosis | 1 | 2018 | 210 | 0.140 |
Why?
|
| Microglia | 2 | 2022 | 1261 | 0.130 |
Why?
|
| Doxorubicin | 1 | 2022 | 2215 | 0.130 |
Why?
|
| Oxazoles | 1 | 2016 | 189 | 0.130 |
Why?
|
| Zirconium | 1 | 2015 | 100 | 0.130 |
Why?
|
| Tissue Distribution | 4 | 2022 | 2335 | 0.130 |
Why?
|
| Adenosine | 1 | 2020 | 823 | 0.130 |
Why?
|
| Carbolines | 1 | 2016 | 265 | 0.120 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2020 | 8925 | 0.110 |
Why?
|
| Cerebrovascular Circulation | 1 | 2023 | 2732 | 0.110 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2021 | 2013 | 0.100 |
Why?
|
| Brain Concussion | 1 | 2023 | 1318 | 0.100 |
Why?
|
| Neuroglia | 1 | 2017 | 925 | 0.100 |
Why?
|
| Metal Nanoparticles | 1 | 2015 | 403 | 0.100 |
Why?
|
| Rats | 6 | 2022 | 24265 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2022 | 8300 | 0.090 |
Why?
|
| Triazoles | 1 | 2016 | 907 | 0.090 |
Why?
|
| Ligands | 3 | 2022 | 3293 | 0.090 |
Why?
|
| Tuberous Sclerosis | 1 | 2018 | 1029 | 0.090 |
Why?
|
| Neurodegenerative Diseases | 1 | 2019 | 1060 | 0.090 |
Why?
|
| Movement | 1 | 2016 | 1470 | 0.090 |
Why?
|
| Hot Temperature | 1 | 2015 | 1355 | 0.090 |
Why?
|
| Amyloid beta-Peptides | 4 | 2023 | 3574 | 0.090 |
Why?
|
| Macaca fascicularis | 2 | 2022 | 908 | 0.090 |
Why?
|
| Contrast Media | 1 | 2022 | 5295 | 0.080 |
Why?
|
| Myocardium | 2 | 2020 | 4775 | 0.080 |
Why?
|
| Models, Theoretical | 1 | 2019 | 3584 | 0.070 |
Why?
|
| Kinetics | 3 | 2022 | 6474 | 0.070 |
Why?
|
| Reproducibility of Results | 3 | 2020 | 19862 | 0.070 |
Why?
|
| Monocytes | 1 | 2015 | 2593 | 0.070 |
Why?
|
| Male | 11 | 2023 | 349538 | 0.070 |
Why?
|
| Mitochondria | 1 | 2018 | 3520 | 0.060 |
Why?
|
| Heart Ventricles | 1 | 2017 | 3801 | 0.060 |
Why?
|
| Humans | 15 | 2023 | 742088 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2023 | 57683 | 0.050 |
Why?
|
| Cricetulus | 1 | 2022 | 817 | 0.050 |
Why?
|
| Permeability | 1 | 2022 | 738 | 0.050 |
Why?
|
| Carbon Radioisotopes | 1 | 2022 | 592 | 0.050 |
Why?
|
| Mitochondria, Heart | 1 | 2022 | 247 | 0.050 |
Why?
|
| Entorhinal Cortex | 1 | 2022 | 264 | 0.050 |
Why?
|
| Primates | 1 | 2022 | 543 | 0.040 |
Why?
|
| Subcutaneous Fat | 1 | 2023 | 391 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2016 | 5522 | 0.040 |
Why?
|
| Fluoroacetates | 1 | 2018 | 14 | 0.040 |
Why?
|
| Aged | 6 | 2023 | 162944 | 0.040 |
Why?
|
| Atrophy | 1 | 2023 | 1576 | 0.040 |
Why?
|
| Cricetinae | 1 | 2022 | 2471 | 0.040 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2022 | 692 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 15108 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 20086 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 2020 | 1135 | 0.040 |
Why?
|
| Choline | 1 | 2018 | 487 | 0.040 |
Why?
|
| Blood-Brain Barrier | 1 | 2022 | 1015 | 0.030 |
Why?
|
| Metabolic Clearance Rate | 1 | 2016 | 379 | 0.030 |
Why?
|
| Middle Aged | 5 | 2023 | 213127 | 0.030 |
Why?
|
| Mice | 5 | 2022 | 81045 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2021 | 1538 | 0.030 |
Why?
|
| Female | 7 | 2023 | 379592 | 0.030 |
Why?
|
| Perfusion Imaging | 1 | 2016 | 195 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2016 | 430 | 0.030 |
Why?
|
| Radioisotopes | 1 | 2015 | 499 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 2021 | 941 | 0.030 |
Why?
|
| Temporal Lobe | 1 | 2022 | 1669 | 0.030 |
Why?
|
| Reference Standards | 1 | 2017 | 1020 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2022 | 1636 | 0.030 |
Why?
|
| Markov Chains | 1 | 2016 | 969 | 0.030 |
Why?
|
| Weight Loss | 1 | 2023 | 2604 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2018 | 1869 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2016 | 1907 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2016 | 2003 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2016 | 2014 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2022 | 18006 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2023 | 3278 | 0.020 |
Why?
|
| Uncertainty | 1 | 2016 | 725 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5062 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 1887 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 35342 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2021 | 5095 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2016 | 2303 | 0.020 |
Why?
|
| Cell Line | 1 | 2021 | 15994 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2016 | 5454 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 9735 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2017 | 2933 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2016 | 8436 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2021 | 19223 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2022 | 21719 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 11363 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 10943 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2016 | 6191 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 21821 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 24913 | 0.010 |
Why?
|
| Adult | 3 | 2023 | 213712 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 14720 | 0.010 |
Why?
|
| Models, Biological | 1 | 2016 | 9581 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2023 | 53187 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2017 | 40450 | 0.010 |
Why?
|
Concepts
(139)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(84)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_